Cargando…
Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma
Immunomodulatory drugs (IMiDs) are profoundly active compounds in the treatment of patients with multiple myeloma (MM). However, despite the fact that treatment with IMiDs has dramatically improved survival for patients with MM, the majority of MM patients develop IMiDs resistance over time. We have...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618648/ https://www.ncbi.nlm.nih.gov/pubmed/28926977 http://dx.doi.org/10.3390/ijms18091999 |
_version_ | 1783267236330340352 |
---|---|
author | Chang, Xiubao Xu, Qinqin Hou, Yuexian Li, Cynthia Xu, Ye Stewart, A. Keith |
author_facet | Chang, Xiubao Xu, Qinqin Hou, Yuexian Li, Cynthia Xu, Ye Stewart, A. Keith |
author_sort | Chang, Xiubao |
collection | PubMed |
description | Immunomodulatory drugs (IMiDs) are profoundly active compounds in the treatment of patients with multiple myeloma (MM). However, despite the fact that treatment with IMiDs has dramatically improved survival for patients with MM, the majority of MM patients develop IMiDs resistance over time. We have found that expression of functional cereblon is required for IMiDs′ action. In addition, it has been reported that cells expressing high levels of cereblon are resistant to proteasome inhibitor, implying that patients with high levels of cereblon should be resistant to proteasome inhibitor. If the above conclusions are correct, cereblon could be considered as a biomarker to determine which standard regimens should be used to treat patients with MM. Unfortunately, the conclusions mentioned above have not been clinically confirmed. In order to confirm these conclusions, we have generated three highly specific mouse monoclonal antibodies (mAbs) against full-length human cereblon. These mAbs can be used to do western blot, immunoprecipitation and immunohistochemistry staining. In addition, their epitopes have been precisely determined and the peptides covering their epitopes completely blocked the antibody binding to cereblon in western blot analysis or in immunohistochemistry staining of MM patients′ specimens. |
format | Online Article Text |
id | pubmed-5618648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56186482017-09-30 Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma Chang, Xiubao Xu, Qinqin Hou, Yuexian Li, Cynthia Xu, Ye Stewart, A. Keith Int J Mol Sci Article Immunomodulatory drugs (IMiDs) are profoundly active compounds in the treatment of patients with multiple myeloma (MM). However, despite the fact that treatment with IMiDs has dramatically improved survival for patients with MM, the majority of MM patients develop IMiDs resistance over time. We have found that expression of functional cereblon is required for IMiDs′ action. In addition, it has been reported that cells expressing high levels of cereblon are resistant to proteasome inhibitor, implying that patients with high levels of cereblon should be resistant to proteasome inhibitor. If the above conclusions are correct, cereblon could be considered as a biomarker to determine which standard regimens should be used to treat patients with MM. Unfortunately, the conclusions mentioned above have not been clinically confirmed. In order to confirm these conclusions, we have generated three highly specific mouse monoclonal antibodies (mAbs) against full-length human cereblon. These mAbs can be used to do western blot, immunoprecipitation and immunohistochemistry staining. In addition, their epitopes have been precisely determined and the peptides covering their epitopes completely blocked the antibody binding to cereblon in western blot analysis or in immunohistochemistry staining of MM patients′ specimens. MDPI 2017-09-17 /pmc/articles/PMC5618648/ /pubmed/28926977 http://dx.doi.org/10.3390/ijms18091999 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chang, Xiubao Xu, Qinqin Hou, Yuexian Li, Cynthia Xu, Ye Stewart, A. Keith Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma |
title | Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma |
title_full | Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma |
title_fullStr | Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma |
title_full_unstemmed | Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma |
title_short | Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma |
title_sort | mouse monoclonal antibodies generated from full length human cereblon: detection of cereblon protein in patients with multiple myeloma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618648/ https://www.ncbi.nlm.nih.gov/pubmed/28926977 http://dx.doi.org/10.3390/ijms18091999 |
work_keys_str_mv | AT changxiubao mousemonoclonalantibodiesgeneratedfromfulllengthhumancereblondetectionofcereblonproteininpatientswithmultiplemyeloma AT xuqinqin mousemonoclonalantibodiesgeneratedfromfulllengthhumancereblondetectionofcereblonproteininpatientswithmultiplemyeloma AT houyuexian mousemonoclonalantibodiesgeneratedfromfulllengthhumancereblondetectionofcereblonproteininpatientswithmultiplemyeloma AT licynthia mousemonoclonalantibodiesgeneratedfromfulllengthhumancereblondetectionofcereblonproteininpatientswithmultiplemyeloma AT xuye mousemonoclonalantibodiesgeneratedfromfulllengthhumancereblondetectionofcereblonproteininpatientswithmultiplemyeloma AT stewartakeith mousemonoclonalantibodiesgeneratedfromfulllengthhumancereblondetectionofcereblonproteininpatientswithmultiplemyeloma |